Trial Profile
Determination of Plasmatic and CSF Levels Of High Doses Of Micafungin in Neonates Suffering from Systemic Candidiasis and/or Candida meningitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs Micafungin (Primary)
- Indications Candidiasis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 17 May 2018 Status changed from active, no longer recruiting to completed.
- 13 Apr 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Apr 2018.
- 13 Apr 2018 Status changed from recruiting to active, no longer recruiting.